Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension

Sarcoidosis-Associated Pulmonary Hypertension (SAPH) is a common finding in patients with chronic sarcoidosis and is associated with increased mortality. The optimal treatment for SAPH is not known; however, therapies approved for Group 1 pulmonary hypertension have improved hemodynamics and functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Abston, Eric, Moll, Matthew, Hon, Stephanie, Govender, Praveen, Berman, Jeffrey, Farber, Harrison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Original Article: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569545/
https://www.ncbi.nlm.nih.gov/pubmed/33093782
http://dx.doi.org/10.36141/svdld.v37i2.9150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569545/
https://www.ncbi.nlm.nih.gov/pubmed/33093782
http://dx.doi.org/10.36141/svdld.v37i2.9150

Ejemplares similares